Bayer Hits Teva With Suit Over Eye Infection Drug

Law360, New York (April 10, 2006, 12:00 AM EDT) -- German pharmaceutical giant Bayer Healthcare AG has sued generic drug maker Teva Pharmaceuticals USA Inc. in an attempt to thwart a generic version of its blockbuster eye infection drug, Vigamox, from entering the marketplace.

Flanked by exclusive licensee Alcon Laboratories, Bayer accused Teva of violating its intellectual property by trying to produce a generic version of the eye drop solution, according to court papers filed in the U.S. District Court for the District of Delaware.

Of the three patents-in-suit, which date back to 1991, two are...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.